CompletedNot Applicable

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Taiwan22 participantsStarted 2018-03-13

Plain-language summary

To evaluate the long-term outcome of active choroidal neovascularization (CNV) in punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) after anti-vascular endothelial factor treatment.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients were punctate inner choroidopathy or multifocal choroiditis with active choroidal neovascularization.
✓. Follow up over 4 years.

Exclusion criteria

✕. Patients were not punctate inner choroidopathy or multifocal choroiditis with active choroidal neovascularization
✕. Patients were punctate inner choroidopathy or multifocal choroiditis with active choroidal neovascularization but loss follow over 1 year.

What they're measuring

Wilcoxon Signed-Rank test

Timeframe: Baseline,48 month.

Trial details

NCT IDNCT03793400

SponsorChanghua Christian Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-04-13

View on ClinicalTrials.gov More Choroidal Neovascularization trials